Business Context and Reporting Period
This Form 8-K, dated August 17, 2026, is a Current Report filed by Olin Corporation (OLN) to supplement the definitive joint proxy statement/prospectus regarding its proposed merger of equals with Huntsman Corporation. The filing was triggered by stockholder complaints and demand letters alleging material omissions in the original proxy disclosures. Olin voluntarily amended the proxy statement to provide additional details on financial analyses, valuation methodologies, and advisor disclosures to avoid delaying the transaction. Special shareholder meetings for both companies are scheduled for August 25, 2026.
Key Financial Metrics and Valuation Data
The filing provides detailed inputs used by financial advisors (Lazard, Citi, and Morgan Stanley) to value the transaction as of March 31, 2026, and share counts as of June 12, 2026.
- Olin Balance Sheet Items (as of March 31, 2026):
- Debt: Approximately $3,016 million (Citi analysis) / $2,838 million (Morgan Stanley analysis).
- Cash and Equivalents: $192 million.
- Net Debt (Lazard): Approximately $2,804 million.
- Fully Diluted Shares: 117.506 million to 117.961 million.
- Huntsman Balance Sheet Items (as of March 31, 2026):
- Debt: Approximately $2,067 million (Citi) / $1,698 million (Morgan Stanley).
- Cash and Equivalents: $369 million.
- Net Debt (Lazard): Approximately $1,908 million.
- Fully Diluted Shares: 178.068 million to 178.241 million.
- Implied Equity Value Ranges (Per Share):
- Olin: $41.40 to $56.30 (Citi DCF); $29.00 to $45.75 (Morgan Stanley Discounted Equity Value).
- Huntsman: $15.20 to $21.80 (Citi DCF); $12.00 to $19.25 (Morgan Stanley Discounted Equity Value); $7.20 to $17.60 (Citi Public Company Analysis).
- Huntsman Standalone Projections (2026-2030):
- 2026 Revenue (Q2-Q4E): $4,729 million.
- 2027 Revenue: $6,613 million.
- 2027 Adjusted EBITDA: $501 million.
- 2027 Unlevered Free Cash Flow: $114 million.
Material Changes and Disclosures
The filing amends the Joint Proxy Statement/Prospectus with the following material clarifications:
- Valuation Methodology: Clarified that Lazard selected comparable companies taking into account "business mix, end-market exposure and other market and macroeconomic factors."
- Financial Inputs: Explicitly disclosed the net debt, cash, and share count figures used by Lazard, Citi, and Morgan Stanley in their respective Discounted Cash Flow (DCF) and Public Company Analyses.
- Advisor Independence: Confirmed that Lazard held no proprietary shares of Olin or Huntsman as of June 15, 2026, and has no commitment to provide future investment banking services to the combined company.
- Projections Update: Clarified that updates to Huntsman's standalone projections were primarily mechanical (e.g., cash tax rates, pension contributions, definition of unlevered free cash flow) rather than changes in business outlook. 2026 revenue was reduced from $6,287 million to $6,150 million.
- Synergies: Explicitly stated that "No estimates of revenue synergies were prepared by Olin management or Huntsman management."
Guidance, Risks, and Contingencies
Management Commentary and Outlook: The Olin Board continues to unanimously recommend that shareholders vote "FOR" the merger proposals. The company asserts that the supplemental disclosures are voluntary and do not constitute an admission of legal necessity or materiality.
Risks and Contingencies:
- Legal Challenges: Two complaints have been filed against Huntsman in New York Supreme Court, and one against Olin in Missouri Circuit Court, alleging negligent misrepresentation and omissions in the proxy statement. The companies intend to defend these actions but are supplementing disclosures to avoid delay.
- Transaction Risks: Risks include failure to obtain shareholder or regulatory approvals, competing offers, inability to achieve synergies, and disruption to business operations.
- Forward-Looking Statements: The filing contains extensive cautionary language regarding the uncertainty of future results, including sensitivity to economic conditions, raw material costs, and cybersecurity risks.
Investor Verification Checklist
- Verify the specific net debt and cash figures used in the valuation models (Lazard vs. Citi vs. Morgan Stanley) as they vary slightly between advisors.
- Review the implied equity value ranges provided by each advisor to understand the valuation spread for both Olin and Huntsman.
- Confirm the status of the pending litigation (Jackson v. Huntsman, Thompson v. Huntsman, Palmer v. Babcock) and whether it impacts the August 25, 2026, shareholder vote.
- Examine the Huntsman standalone projections for 2026-2030, noting the reduction in 2026 revenue and the mechanical nature of the adjustments.
- Check the advisor independence disclosures regarding Lazard's holdings and future engagement commitments.